MissionIR Interview With CytRx Embellishes on Clinical Trial Results and Plans for an Incredible 2014
Marketwire - Thu Jan 16, 7:30AM CST
MissionIR today announces the online availability of its interview with CytRx Corp. (NASDAQ: CYTR) President and Chief Executive Officer Steven Kriegsman, as well as the company's vice president of business development and investor relations David Haen. The full audio interview is available at the following link: http://CYTR.MissionIR.com/interview-jan2014.html.
CYTR: 2.58 (+0.03)